Headquartered in the Netherlands, the Company has a Science and Engineering Center in Switzerland and a US office in Boston, ...

NS Pharma, Inc. (NS Pharma) a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that the U.S. Food & Drug Administration (FDA) has granted Orphan Drug Designation to NS-229, ...

The US FDA is currently reviewing its pharmaceutical ... Most importantly, the FDA intends to actively discourage the use of logos, bars, stripes, watermark graphics, lines, and symbols on ...

The Food and Drug Administration is suspending a quality control program for its food testing laboratories as a result of ...

U.S. Food and Drug Administration Commissioner Martin Makary announced on Thursday a policy to limit employees of companies ...

The Food and Drug Administration is scrambling to hire contractors to replace fired employees who helped plan thousands of ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...

The recall has been categorized as “Class II,” meaning any contaminated product could cause “temporary or medically reversible adverse health consequences,” according to ...

Equillium (EQ) announced that the company has received feedback from its Type D meeting with the FDA to discuss the regulatory pathway for ...

The FDA plans to remove synthetic food dyes due to health concerns. Learn more about the transition to natural color ...

Key measures include setting a national standard and timeline for transitioning to natural food colorings, revoking the use ...